Serum fibroblast growth factor 19 and calcium channel α2δ1 subunit as diagnostic biomarkers for hepatocellular carcinoma

Dynamic changes of systemic inflammatory markers and their association with radiologic progression and hepatotoxicity in patients with hepatocellular carcinoma on systemic therapy